Keywords
SARS-CoV-2
cerebral venous thrombosis
How to Cite
Abstract
Cerebral sinus venous thrombosis (CSVT) is an uncommon disease affecting mainly young women. Several risk factors have been described, such as thrombophilia, cancer, oral contraception and pregnancy. Headache is the most common clinical manifestation. Here we describe the case of a young man without risk factors who developed CSVT in association with SARS-CoV-2 bilateral pneumonia.
He was treated with anticoagulants with good clinical outcome. A possible association between SARSCoV-2 infection and occurrence of CSVT has been described since COVID-19 pandemic began. Pathophysiology has been linked to endotelial injury and
hypercoagulable state seen in severe forms of disease. Anticoagulation with vitamin K antagonist for a period of three months is the treatment of choice, but specifically directed clinical trials are required in order to define a best therapeutic strategy in this special patient population.
References
Silvis SM, Aguiar de Sousa D, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13:555-565.
Ropper AH, Klein JP. Cerebral venous thrombosis. N Engl J Med. 2021;385:59-64.
Dakay C, Cooper J, Bloomfield J y col. Cerebral venous sinus thrombosis in COVID-19 infection: a case series and review of the literature. J Stroke Cerebrovasc Dis. 2021;30(1):105434.
Klein DE, Libman R, Kirsch C, Arora R. Cerebral venous thrombosis: atypical presentation of COVID-19 in the young. J Stroke Cerebrovasc Dis.2020;29(8):104989.
Al-Mufti F, Amuluru K, Sahni R y col. Cerebral venous thrombosis in COVID-19: a New York metropolitan cohort study. Am J Neuroradiol. 2021;42(7):1196-1200.
Şimşek F, Tosunoğlu R. Massive cerebral venous thrombosis and venous watershed infarction as late complications of COVID-19: a case report. Neurol Sci. 2021 Nov;42(11):4421-4423.
Ghosh R, Roy D, Mandal A y col. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr. 2021;15(3):1039-1045.
Medicherla CB, Pauley RA, De Havenon A, Yaghi S, Ishida K, Torres JL. Cerebral venous sinus thrombosis in the COVID-19 pandemic. J Neuroophthalmol. 2020;40:457-462
All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar